RVMD Presents Clinical Data
Revolution Medicines to present clinical data from RAS(ON) inhibitor combination trials in pancreatic cancer at ESMO Gastrointestinal Cancers Congress 2026
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Revolution Medicines to present clinical data from RAS(ON) inhibitor combination trials in pancreatic cancer at ESMO Gastrointestinal Cancers Congress 2026